Sino Biopharmaceutical Limited
Status: Publicly traded
Direct answer
Sino Biopharmaceutical Limited is publicly traded on HKSE under the ticker 1177.HK.
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike...
Can you invest in Sino Biopharmaceutical Limited?
Yes. Sino Biopharmaceutical Limited is publicly traded on HKSE under the ticker 1177.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sino Biopharmaceutical Limited
Detailed equity research is provided by MarketSnap.